Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 104 entries
View as:

A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT05415462 Org: User:
Start: 06/06/22 End: 09/04/23 Due: 09/04/24

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05085366 Org: User:
Start: 10/26/21 End: 04/06/28 Due: 04/06/29

A Study to Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind

Phase: N/A Priority: Normal
NCT ID: NCT05367908 Org: User:
Start: 04/11/22 End: 08/14/22 Due: 08/14/23

A Study of the Effectiveness of Moderna COVID-19 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT05933304 Org: User:
Start: 12/18/20 End: 11/17/23 Due: 11/17/24

A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05975099 Org: User:
Start: 07/26/23 End: 07/31/25 Due: 07/31/26

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

Phase: N/A Priority: Normal
NCT ID: NCT05743881 Org: User:
Start: 02/15/23 End: 09/30/26 Due: 09/30/27

An Observational Study of Moderna COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)

Phase: N/A Priority: Normal
NCT ID: NCT05765578 Org: User:
Start: 03/08/23 End: 06/17/24 Due: 06/17/25

A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT04796896 Org: User:
Start: 03/15/21 End: 03/15/24 Due: 03/15/25

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05606965 Org: User:
Start: 11/02/22 End: 11/11/25 Due: 11/11/26

A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04649151 Org: User:
Start: 12/09/20 End: 06/14/24 Due: 06/14/25

A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT06113692 Org: User:
Start: 03/31/23 End: 06/30/25 Due: 06/30/26

A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05972174 Org: User:
Start: 07/10/23 End: 07/16/24 Due: 07/16/25

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-1944 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03829384 Org: User:
Start: 01/22/19 End: 06/07/21 Due: 06/07/22

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05330975 Org: User:
Start: 04/01/22 End: 11/08/24 Due: 11/08/25

A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04956575 Org: User:
Start: 07/06/21 End: 09/27/22 Due: 09/27/23

A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04470427 Org: User:
Start: 07/27/20 End: 12/29/22 Due: 12/29/23

A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT06097273 Org: User:
Start: 10/19/23 End: 05/28/24 Due: 05/28/25

A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus

Phase: N/A Priority: Normal
NCT ID: NCT06097299 Org: User:
Start: 10/24/23 End: 06/30/25 Due: 06/30/26

Use of Wearable Digital Sensors After mRNA Vaccination in Adults

Phase: N/A Priority: Normal
NCT ID: NCT05440318 Org: User:
Start: 06/16/22 End: 02/07/23 Due: 02/07/24

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

Phase: N/A Priority: Normal
NCT ID: NCT06130345 Org: User:
Start: 04/14/23 End: 08/31/24 Due: 08/31/25

A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older

Phase: N/A Priority: Normal
NCT ID: NCT05566639 Org: User:
Start: 09/14/22 End: 01/05/24 Due: 01/05/25

Post-Marketing Safety Study of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in the United States

Phase: N/A Priority: Normal
NCT ID: NCT04958954 Org: User:
Start: 07/07/21 End: 06/30/23 Due: 06/30/24

A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants

Phase: N/A Priority: Normal
NCT ID: NCT04927065 Org: User:
Start: 05/28/21 End: 11/17/23 Due: 11/17/24

A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05827926 Org: User:
Start: 04/14/23 End: 12/03/24 Due: 12/03/25

A Study of Modified mRNA Vaccines in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05397223 Org: User:
Start: 05/24/22 End: 02/21/26 Due: 02/21/27